NCT06195553 Application and Effectiveness of the STEPPS in Patients with BPD, Extending to Their Families with the FC Program
| NCT ID | NCT06195553 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitat Jaume I |
| Condition | Borderline Personality Disorder (BPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-01-02 |
| Primary Completion | 2025-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2024-01-02 with a primary completion date of 2025-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present research project is framed within the issue of Borderline Personality Disorder (BPD). This condition stands as one of the most common challenges encountered within the mental health services of the National Health System. The primary objectives of this research are to verify whether the combined use of established treatments for patients and their families, conducted in parallel, leads to a greater improvement in patients and their families, respectively. Additionally, another aim of the project is to assess efficiency, defined as the acceptance of intervention programs by patients, their families, and clinical professionals, as well as to demonstrate their feasibility.
Eligibility Criteria
PATIENTS Inclusion Criteria: * Being at least 18 years old. * Be a patients with symptoms compatible with a diagnosis of BPD who is undergoing treatment or follow-up in someone of the indicated recruitment centers. * Sign an informed consent. Exclusion Criteria: * The presence of any pathology that prevents carrying out the intervention: major depression, psychosis, schizophrenia, substance dependence, eating disorders, another personality disorder, borderline IQ, etc., which due to its severity is currently interfering. FAMILIES: Inclusion Criteria: * Being at least 18 years old. * Be a relative of someone of the patients with symptoms compatible with a diagnosis of BPD who is undergoing treatment or follow-up in someone of the indicated recruitment centers. * Sign an informed consent. Exclusion Criteria: * The presence of any pathology that prevents carrying out the intervention: major depression, psychosis, schizophrenia, substance dependence, eating disorders, another personality disorder, borderline IQ, etc., which due to its severity is currently interfering.
Contact & Investigator
Soledad Quero, Psychology
STUDY DIRECTOR
Universidad Jaume I
Frequently Asked Questions
Who can join the NCT06195553 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Borderline Personality Disorder (BPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06195553 currently recruiting?
Yes, NCT06195553 is actively recruiting participants. Contact the research team at lopez_chrcru@gva.es for enrollment information.
Where is the NCT06195553 trial being conducted?
This trial is being conducted at Castellon, Spain.
Who is sponsoring the NCT06195553 clinical trial?
NCT06195553 is sponsored by Universitat Jaume I. The principal investigator is Soledad Quero, Psychology at Universidad Jaume I. The trial plans to enroll 120 participants.